Clinical Trial Update: Cilengitide in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cilengitide in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | Status: COMPLETED